Prognoza

Nie mamy danych analityków dla tej spółki.

Wiadomości Przejdź do aktualności

Syncona issues 9,330 new shares for long-term incentive plan

Syncona has announced the issuance of 9,330 new ordinary shares to meet obligations under a long-term incentive plan. The new shares represent around 0.002% of existing ordinary shares and were calculated based on a mid-price of £1.07 per share; recipients may not sell or transfer the shares for one year. The company has applied for admission to the official market; trading is expected to commence on Thursday. » Więcej na de.investing.com
Syncona shareholders approve new investment strategy and long-term incentive schemes

Shareholders of Syncona approved the new investment strategy with around 89.6% and the new long-term incentive schemes with 89.4%. As of the record date there were 672,549,420 issued ordinary shares, of which 64,356,396 were treasury shares; voting rights amounted to 608,193,024. Rob Hutchinson has resigned from the board; the board intends to appoint a new non-executive member with investment company expertise and to keep the total number of members at five. All resolutions passed at the general meeting will be submitted to the National Storage Mechanism and are set out in the explanatory circular. » Więcej na de.investing.com
Syncona to ask shareholders to vote on new investment policy and remuneration structure on March 3

Syncona is putting proposals to shareholders to change its investment policy and the investment team's remuneration. Plans include a review of capital allocation within two years or after the return of £250m, and a cap on new investments in early-stage companies at £15m each for the financial years ending September 2026 and 2027 and a maximum of 5% of NAV as of 30 September 2025. The new remuneration structure ties bonuses to the realisation of portfolio assets and allows partial payments in market-purchased Syncona shares. The Wellcome Trust, with around 30.58% of voting rights, has announced its support. » Więcej na de.investing.com

Historyczne dywidendy Dywidendy

Wszystkie wskaźniki dywidendowe Wszystkie wskaźniki

W 2019 roku SYNCONA LS wypłaciła już 0,0252 € dywidend. Ostatnia wypłata nastąpiła w lipiec 2019.

Dane finansowe spółki

W ostatnim kwartale SYNCONA LS osiągnęła przychody w wysokości 42,72 mln € i zysk netto w wysokości 19,06 mln €

(EUR)	marzec 2026	YoY
Przychody	42,72 mln	-
Zysk brutto	42,72 mln	-
Zysk netto	19,06 mln	-
EBITDA	19,06 mln	-

Dane fundamentalne

Wskaźnik	Wartość
Kapitalizacja rynkowa	796,17 mln €
Liczba akcji	608,19 mln
Maksimum/minimum z 52 tygodni	1,37 € - 1,01 €
Dywidendy	Nie
Beta	0,36
C/Z (PE Ratio)	-77,78
PEG (PEG Ratio)	-0,50
C/WK (PB Ratio)	0,66
C/S (PS Ratio)	11,88

Profil spółki

Syncona Limited ist ein Fonds, der auf Investitionen in Hedge-, Aktien- und langfristige alternative Investmentfonds in verschiedenen Anlageklassen spezialisiert ist. Er verwaltet Private Equity, Schuldtitel, festverzinsliche und alternative Anlagen. Der Fonds investiert vorzugsweise in den Gesundheits- und Biowissenschaftssektor mit Schwerpunkt auf Zelltherapie, Gentherapie, Biologika und kleinen Molekülen. Der Fonds investiert weltweit in die öffentlichen Aktien- und Rentenmärkte. Er strebt attraktive mittel- bis langfristige Renditen an, indem er in führende Long-only- und alternative Investmentfonds mit bewährten Managern und über mehrere Anlageklassen hinweg investiert. Das Unternehmen investiert in separat verwaltete Kontenportfolios.